| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |